亚急性甲状腺炎治疗过程中的超声检查分期及其临床意义  

Clinical Significance of Ultrasonic Staging in Treatment of Subacute Thyroiditis

作　　者：贺冶冰[1] 吕志红[1] 陈晓雯[1] 王从农[1] 陈勇[1] 黄天韬[1] 

机构地区：[1]湖北省黄石市中心医院

出　　处：《内科急危重症杂志》2004年第3期141-142,共2页Journal of Critical Care In Internal Medicine

摘　　要：目的 :探讨超声检查对亚急性甲状腺炎 (亚甲炎 )治疗过程的分期及对指导用药的意义。方法 :12例亚甲炎患者随机分成泼尼松组 (P组 )和非甾体抗炎药组 (N组 )。治疗前和治疗后每 2周进行 1次甲状腺超声检查。治疗后发现回声低减区缩小 (中期 ) ,开始逐步减少药量。回声低减区基本消失时 (恢复期 )停药。结果 :两组临床过程分别与各阶段超声改变有密切联系。超声可作为亚甲炎分期客观依据。结论Objective: To investigate the value of ultrasonic staging and its significance in guiding medication during the treatment of subacute thyroiditis. Methods: Twelve patients with subacute thyroiditis were randomly divided into two groups. P group were treated with prednisone and N group with nonsteroidol anti-inflammatory drugs. Thyroid glands of all patients were examined by ultrasonography before and once every 2 weeks after initiation of treatments. It is the time for dose tapering when there were reduction of low echo areas demonstrated by ultrasonography (middle stage). Medications were discontinued when low echo areas couldn't be found (stage of recovery). Results: There is close relationship between clinical manifestations and ultrasonographic findings in each group. Ultrasonography can offer an objective evidence for staging of subacute thyroiditis. Conclusion: Subacute thyroiditis could be successfully cured with adjustment of drug dosage according to the staging by ultrasonography.

关 键 词：亚急性甲状腺炎 超声检查 泼尼松 非甾体抗炎药 

分 类 号：R581.4[医药卫生—内分泌]